Lazari Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
Lazari Capital Management's AMGN Position: Q2 2026 in Review
Lazari Capital Management reduced its Amgen (AMGN) stake by 15% in Q2 2026, selling an estimated $112K and leaving 1,870 shares worth $677K. The position accounts for 0.21% of the portfolio, ranked #83.
Lazari Capital Management first reported a position in AMGN in Q2 2023 and has held it in 13 quarters since. The position peaked at $862K in Q2 2023. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Lazari Capital Management held 1,870 shares of Amgen worth $677K as of Q2 2026.
- Lazari Capital Management sold 326 Amgen shares in Q2 2026, an estimated $112K.
- Amgen made up 0.21% of Lazari Capital Management's portfolio in Q2 2026, its #83 holding.
- Lazari Capital Management first reported a position in Amgen in Q2 2023 and has held it in 13 quarters since.
- Lazari Capital Management's Amgen position peaked at $862K in Q2 2023.
- 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Lazari Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.